Class I - Evidencia y
consenso |
Unfractionated heparin (UFH). |
Bivalirudin or argatroban instead of heparin in patients
with heparin-induced thrombocytopenia. |
Class IIa - The weight of
evidence or opinion is in favor of using antithrombotic
drugs in patients undergoing PCI the following manner: |
Bivalirudin as an alternative to UFH and glycoprotein
IIb/IIIa inhibitors elective PCI in low risk patients. |
Low molecular weight heparin (LMWH) as an alternative to
UFH in patients with a non-ST elevation acute coronary
syndrome. |
Class IIb - The weight of
evidence or opinion is less well established for the
benefit of LMWH in patients undergoing PCI in the
following setting: |
LMWH as an alternative to UFH in patients with ST
elevation myocardial infarction. |